Skip to navigation Skip to main content Skip to footer

Winter Scientific Conference 2022

Watch the whole UK Biobank Winter Scientific Conference on demand!

The UK Biobank Winter Scientific Conference took place on Thursday the 8th of December 2022, and is now available to watch on demand. We hope you were there and enjoyed it just as much as we did.  We also look forward to hearing more about novel scientific results and exciting future developments in the future as a result of use of the UK Biobank resource. 

View the full agenda

Multi-omics in UK Biobank

This session covered the potential for vast amounts of new data to be generated from UK Biobank’s biological samples. Including information about the measurement and analysis of metabolomics, proteomics, epigenetics and infectious disease markers in UK Biobank for health-related research.

Professor Valerie O’Donnell, Cardiff University: Session Chair

Dr Chris Whelan, Janssen: The story so far – the UK Biobank Pharma Proteomics Project

Heli Julkunen, Senior Data Scientist, Nightingale Health: The value of metabolomics data in UK Biobank

Professor Wolf Reik, Altos: Epigenetic assay strategies

Dr Charlotte Warren-Gash, LSHTM: Measuring infectious markers in UK Biobank and its potential value

Panel Discussion

How UK Biobank is enabling dementia research

The first of our afternoon sessions explored how UK Biobank is enabling dementia research, and provided insights into how repeat imaging and digital tools could be used to better characterise cognitive decline and disease classification.

Professor Julie Williams, UK DRI: Session Chair

Professor Paul Matthews, Imperial College London: Added value of repeat imaging and assays

Professor David Llewellyn, Exeter University: Multimorbidity and dementia risk

Professor James Rowe, University of Cambridge: Prediagnostic supranuclear palsy

Professor Valentina Escott-Price, Cardiff University: The use of genetic risk scores to stratify populations for dementia risk

Panel discussion

Enhanced health outcomes data in UK Biobank

Our final session covered UK Biobank's strategy for incorporating new data on health outcomes into the resource. This includes linkage to cancer histopathology datasets, and ophthalmic healthcare records. The session also covered approaches needed to characterise health outcomes at-scale across diverse health record data.

Professor John Danesh, Cambridge University: Session chair

Professor Naomi Allen, UK Biobank: UK Biobank's strategy for phenotyping health outcomes

Professor Josh Denny, NIH: Use of automated approaches for outcome phenotyping using existing linkages

Kezia Gaitskell, University of Oxford: Value of digital histopathology slides for phenotyping cancer outcomes

Anthony Khawaja, University College London: Value of linking to ophthalmic healthcare records

Panel discussion

Last updated